Trial Profile
A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft as Measured by In-Vivo Confocal Microscopy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Mar 2021
Price :
$35
*
At a glance
- Drugs Alcaftadine (Primary)
- Indications Allergic conjunctivitis
- Focus Therapeutic Use
- Sponsors Ora Inc
- 21 Oct 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Dec 2014 New trial record